[Prolonged intravenous infusion chemotherapy. General review of theoretical bases and results].
Continuous intravenous infusion of chemotherapy is now widely used to enhance the therapeutic index of cancer drugs. Cellular kinetics and pharmacological basis for protracted intravenous chemotherapy are reviewed for the main available drugs. From the increasingly published data it is now possible to separate routine and research utilization of protracted infusion chemotherapy.
G
G
Ganem
P
P
Carde
A
A
Gouyette
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000378:metabolism; D001761:Bleomycin / Q000008:administration & dosage; D002453:Cell Cycle; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007263:Infusions, Parenteral; D009369:Neoplasms / Q000473:pathology; D011034:Podophyllotoxin / Q000008:administration & dosage; D013997:Time Factors; D014748:Vinca Alkaloids / Q000008:administration & dosage
D000970:Antineoplastic Agents; D014748:Vinca Alkaloids; D003561:Cytarabine; D001761:Bleomycin; D004317:Doxorubicin; D011034:Podophyllotoxin; D002945:Cisplatin; D005472:Fluorouracil
La chimiothérapie en perfusion intraveineuse prolongée. Revue générale des bases théoriques et résultats.